On Monday, the World Health Organisation suspends clinical trials of Hydroxychloriquine as a potential treatment for covid-19.
The decision came after the publication last week of a study in the Lancet indicating that using the drug on COVID-19 patients could increase their likelihood of dying, WHO chief Tedros Adhanom Ghebreyesus told a virtual press conference.
WHO chief scientist Soumya Swaminathan meanwhile told Monday’s briefing that the WHO-backed Solidarity Trial had been looking only at the effects of hydroxychloroquine and not chloroquine.
No comments:
Post a Comment